Hillhouse Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Hillhouse Investment Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$128M	Hold	1,034,306	–	–	4.09%	5
2019 Q1	$137M	Hold	1,034,306	–	–	5.7%	5
2018 Q4	$145M	Sell	1,034,306 -4,437,953	-81%	-$589M	10.86%	3
2018 Q3	$942M	Hold	5,472,259	–	–	25.19%	1
2018 Q2	$841M	Hold	5,472,259	–	–	14.34%	2
2018 Q1	$919M	Buy	5,472,259 +1,575,477	+40%	+$213M	16.22%	2
2017 Q4	$381M	Hold	3,896,782	–	–	6.46%	5
2017 Q3	$403M	Buy	3,896,782 +176,056	+5%	+$13.1M	6.66%	4
2017 Q2	$167M	Buy	3,720,726 +2,355,906	+173%	+$92.8M	2.58%	9
2017 Q1	$50M	Hold	1,364,820	–	–	0.97%	15
2016 Q4	$41.4M	Buy	1,364,820 +664,820	+95%	+$20.9M	0.92%	12
2016 Q3	$21.6M	Hold	700,000	–	–	0.44%	16
2016 Q2	$20.9M	Hold	700,000	–	–	0.53%	10
2016 Q1	$20.5M	Buy	+700,000	New	+$19.8M	0.45%	10

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Hillhouse Investment Management's ONC Position: Q2 2019 in Review

Hillhouse Investment Management held its BeOne Medicines Ltd (ONC) position steady in Q2 2019 at 1,034,306 shares worth $128M. The position accounts for 4.09% of the portfolio, ranked #5.

Hillhouse Investment Management first reported a position in ONC in Q1 2016 and has held it in 14 quarters since. The position peaked at $942M in Q3 2018. 203 funds tracked by Wall St. Rank hold ONC as of Q2 2019.

Hillhouse Investment Management held 1,034,306 shares of BeOne Medicines Ltd worth $128M as of Q2 2019.
Hillhouse Investment Management left its BeOne Medicines Ltd share count unchanged in Q2 2019.
BeOne Medicines Ltd made up 4.09% of Hillhouse Investment Management's portfolio in Q2 2019, its #5 holding.
Hillhouse Investment Management first reported a position in BeOne Medicines Ltd in Q1 2016 and has held it in 14 quarters since.
Hillhouse Investment Management's BeOne Medicines Ltd position peaked at $942M in Q3 2018.
203 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2019.

Based on Hillhouse Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.